
Cronos Group Inc.
USD2.85
-0.00 (-0.04%)
CEO
Michael Ryan Gorenstein
IPO Date
2018-02-27
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
CA
Open
$2.86
Prev. Close
$2.85
Day Low
$2.83
Day High
$2.87
52W Low
$1.91
52W High
$3.43
Market Cap
$1.06B
Volume
0.05M
| 18.7 |
| 31 Dec 2023 | FY | 13.7% | -84.8% | -6.7% | -6.5% | 0.00 | 22.54 | -10.8 |
| 31 Dec 2022 | FY | 17.8% | -194.5% | -14.9% | -14.0% | 0.00 | 14.10 | -5.5 |
| 31 Dec 2021 | FY | -27.3% | -613.5% | -29.4% | -28.1% | 0.01 | 20.02 | -3.7 |
| 31 Dec 2020 | FY | -55.3% | -156.5% | -4.3% | -3.8% | 0.01 | 6.63 | -32.8 |
| 31 Dec 2019 | FY | -74.1% | 4911.6% | 65.0% | 54.4% | 0.00 | 4.72 | 3.1 |
| 31 Dec 2018 | FY | 51.3% | -178.5% | -11.5% | -12.2% | 0.08 | 1.20 | -106.0 |
| 31 Dec 2017 | FY | 50.0% | -47.1% | -1.7% | -1.8% | 0.05 | 4.27 | -938.0 |
| 31 Dec 2016 | FY | -90.9% | -149.7% | -3.5% | -2.8% | 0.12 | 1.04 | -131.6 |
| -136.0 |
| 30 Sept 2025 | Q3 | 50.4% | 71.4% | 2.4% | 2.2% | 0.00 | 22.45 | 10.3 |
| 30 Jun 2025 | Q2 | 43.4% | -118.7% | -3.7% | -3.4% | 0.00 | 24.65 | -4.7 |
| 31 Mar 2025 | Q1 | 41.0% | 19.0% | 0.6% | 0.5% | 0.00 | 27.80 | 22.4 |
| 31 Dec 2024 | Q4 | 29.6% | 144.3% | 4.1% | 3.7% | 0.00 | 18.84 | 4.4 |
| 30 Sept 2024 | Q3 | 31.3% | 24.4% | 0.8% | 0.7% | 0.00 | 24.24 | 25.4 |
| 30 Jun 2024 | Q2 | 22.7% | -31.5% | -0.8% | -0.8% | 0.00 | 28.29 | -24.7 |
| 31 Mar 2024 | Q1 | 17.7% | -8.9% | -0.2% | -0.2% | 0.00 | 28.19 | -112.3 |
| 31 Dec 2023 | Q4 | 8.0% | -187.3% | -4.1% | -3.9% | 0.00 | 22.54 | -4.4 |